The relationship between pain and prescription opioid abuse is poorly understood. Determining whether a patient is seeking additional opioid medications in order to alleviate pain or to abuse the drugs can be difficult. The present study was designed to evaluate two variables that may influence the abuse liability of opioids: drug use history and the presence or absence of experimentally induced pain. Eighteen healthy participants completed this outpatient study. One group was abusing prescription opioids (N=9) and one group had used prescription opioids medically but did not abuse them (N=9). All participants completed twelve sessions during which the effects of orally delivered oxycodone (0, 15, 30 mg/70 kg, PO) were examined. One dose was tested per day under double-blind conditions and sessions were separated by at least 48 h. During the first "sample" session each week, participants were given $10 and the dose that was available later that week. During the second "choice" session, participants could self-administer either money or the previously sampled dose. Six sessions involved repeated hand immersions in cold water (4°C) and six sessions involved immersions in warm water (37°C). Most of the positive subjective effects of oxycodone were similar between the groups, but oxycodone selfadministration significantly differed between groups. Non-abusers self-administered active doses © 2009 Elsevier Ireland Ltd. All rights reserved.Address Correspondence To: Sandra D. Comer, Ph.D., Department of Psychiatry, Columbia University and the New York State Psychiatric, 1051 Riverside Dr., Unit 120, New York, NY 10032, sdc10@columbia.edu, phone: (212) FAX: (212) 543-5991. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. CONTRIBUTORS S.D. Comer designed the study, analyzed the data, and wrote the paper. W.J. Kowalczyk collected data and provided preliminary statistical analyses of the results. J. Houser wrote first drafts of the Introduction and Methods sections of the paper. M.A. Sullivan provided overall medical coverage during the study. S.K. Vosburg interviewed potential participants and supervised data collection. All of the co-authors read drafts of the paper. The authors gratefully acknowledge the nursing care provided by Ms. Janet Murray and Ronnie Shapiro, as well as the technical assistance of Ms. Susanna Stephens.
CONFLICT OF INTERESTS.D.C. has served as a consultant to Abbott Pharmaceuticals, Alpharma Pharmaceuticals LLC, BioDelivery Sciences Inc., Cephalon Pharmaceuticals, King Pharmaceuticals, Pain Therapeutics, and Purdue Pharmaceuticals, manufacturers ...